BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16688207)

  • 21. IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies.
    Leborgne C; Barbon E; Alexander JM; Hanby H; Delignat S; Cohen DM; Collaud F; Muraleetharan S; Lupo D; Silverberg J; Huang K; van Wittengerghe L; Marolleau B; Miranda A; Fabiano A; Daventure V; Beck H; Anguela XM; Ronzitti G; Armour SM; Lacroix-Desmazes S; Mingozzi F
    Nat Med; 2020 Jul; 26(7):1096-1101. PubMed ID: 32483358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An essential receptor for adeno-associated virus infection.
    Pillay S; Meyer NL; Puschnik AS; Davulcu O; Diep J; Ishikawa Y; Jae LT; Wosen JE; Nagamine CM; Chapman MS; Carette JE
    Nature; 2016 Feb; 530(7588):108-12. PubMed ID: 26814968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.
    Boutin S; Monteilhet V; Veron P; Leborgne C; Benveniste O; Montus MF; Masurier C
    Hum Gene Ther; 2010 Jun; 21(6):704-12. PubMed ID: 20095819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vivo characterization of newly discovered myotropic adeno-associated vectors.
    Ji J; Lefebvre E; Laporte J
    Skelet Muscle; 2024 May; 14(1):9. PubMed ID: 38702726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mitoTALEN reduces the mutant mtDNA load in neurons.
    Bacman SR; Barrera-Paez JD; Pinto M; Van Booven D; Stewart JB; Griswold AJ; Moraes CT
    Mol Ther Nucleic Acids; 2024 Mar; 35(1):102132. PubMed ID: 38404505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of DNA-dependent protein kinase catalytic subunit boosts rAAV transduction of polarized human airway epithelium.
    Ning K; Zhang X; Feng Z; Hao S; Kuz CA; Cheng F; Park SY; McFarlin S; Engelhardt JF; Yan Z; Qiu J
    Mol Ther Methods Clin Dev; 2023 Dec; 31():101115. PubMed ID: 37841417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional gene delivery to and across brain vasculature of systemic AAVs with endothelial-specific tropism in rodents and broad tropism in primates.
    Chen X; Wolfe DA; Bindu DS; Zhang M; Taskin N; Goertsen D; Shay TF; Sullivan EE; Huang SF; Ravindra Kumar S; Arokiaraj CM; Plattner VM; Campos LJ; Mich JK; Monet D; Ngo V; Ding X; Omstead V; Weed N; Bishaw Y; Gore BB; Lein ES; Akrami A; Miller C; Levi BP; Keller A; Ting JT; Fox AS; Eroglu C; Gradinaru V
    Nat Commun; 2023 Jun; 14(1):3345. PubMed ID: 37291094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rescue of infant progressive familial intrahepatic cholestasis type 3 mice by repeated dosing of AAV gene therapy.
    Weber ND; Odriozola L; Ros-Gañán I; García-Porrero G; Salas D; Argemi J; Combal JP; Kishimoto TK; González-Aseguinolaza G
    JHEP Rep; 2023 May; 5(5):100713. PubMed ID: 37096142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Therapy Strategies Targeting Aging-Related Diseases.
    Yu J; Li T; Zhu J
    Aging Dis; 2023 Apr; 14(2):398-417. PubMed ID: 37008065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional gene delivery to and across brain vasculature of systemic AAVs with endothelial-specific tropism in rodents and broad tropism in primates.
    Chen X; Wolfe DA; Bindu DS; Zhang M; Taskin N; Goertsen D; Shay TF; Sullivan E; Huang SF; Kumar SR; Arokiaraj CM; Plattner V; Campos LJ; Mich J; Monet D; Ngo V; Ding X; Omstead V; Weed N; Bishaw Y; Gore B; Lein ES; Akrami A; Miller C; Levi BP; Keller A; Ting JT; Fox AS; Eroglu C; Gradinaru V
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting reactive astrocytes by pH-responsive ligand-bonded polymeric nanoparticles in spinal cord injury.
    Sabourian P; Frounchi M; Kiani S; Mashayekhan S; Kheirabadi MZ; Heydari Y; Ashraf SS
    Drug Deliv Transl Res; 2023 Jun; 13(6):1842-1855. PubMed ID: 36689118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis.
    Derkaev AA; Ryabova EI; Esmagambetov IB; Shcheblyakov DV; Godakova SA; Vinogradova ID; Noskov AN; Logunov DY; Naroditsky BS; Gintsburg AL
    Front Microbiol; 2022; 13():960937. PubMed ID: 36238585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical studies in Krabbe disease: A model for the investigation of novel combination therapies for lysosomal storage diseases.
    Heller G; Bradbury AM; Sands MS; Bongarzone ER
    Mol Ther; 2023 Jan; 31(1):7-23. PubMed ID: 36196048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A versatile toolkit for overcoming AAV immunity.
    Li X; Wei X; Lin J; Ou L
    Front Immunol; 2022; 13():991832. PubMed ID: 36119036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid.
    Goertsen D; Goeden N; Flytzanis NC; Gradinaru V
    Mol Ther Methods Clin Dev; 2022 Sep; 26():331-342. PubMed ID: 35990749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemically targeted cancer immunotherapy and gene delivery using transmorphic particles.
    Asavarut P; Waramit S; Suwan K; Marais GJK; Chongchai A; Benjathummarak S; Al-Bahrani M; Vila-Gomez P; Williams M; Kongtawelert P; Yata T; Hajitou A
    EMBO Mol Med; 2022 Aug; 14(8):e15418. PubMed ID: 35758207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene Therapy for Acquired and Genetic Cholestasis.
    Martínez-García J; Molina A; González-Aseguinolaza G; Weber ND; Smerdou C
    Biomedicines; 2022 May; 10(6):. PubMed ID: 35740260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular Vesicles as Novel Drug-Delivery Systems through Intracellular Communications.
    Matsuzaka Y; Yashiro R
    Membranes (Basel); 2022 May; 12(6):. PubMed ID: 35736256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle regeneration affects Adeno Associated Virus 1 mediated transgene transcription.
    Mollard A; Peccate C; Forand A; Chassagne J; Julien L; Meunier P; Guesmia Z; Marais T; Bitoun M; Piétri-Rouxel F; Benkhelifa-Ziyyat S; Lorain S
    Sci Rep; 2022 Jun; 12(1):9674. PubMed ID: 35690627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. dCas9-VPR-mediated transcriptional activation of functionally equivalent genes for gene therapy.
    Riedmayr LM; Hinrichsmeyer KS; Karguth N; Böhm S; Splith V; Michalakis S; Becirovic E
    Nat Protoc; 2022 Mar; 17(3):781-818. PubMed ID: 35132255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.